Lantern Pharma Inc. Retained Earnings
Lantern Pharma Inc. (LTRN) had Retained Earnings of -$103.55 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-14
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$103.55M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$96.47M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$93.15M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$89.07M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | -$103.55M 10-Q · filed 2026-08-14 |
| 2026-03-31 | -$96.47M 10-Q · filed 2026-05-15 |
| 2025-12-31 | -$93.15M 10-Q · filed 2026-08-14 |
| 2025-09-30 | -$89.07M 10-Q · filed 2025-11-12 |
| 2025-06-30 | -$84.89M 10-Q · filed 2025-08-13 |
| 2025-03-31 | -$80.56M 10-Q · filed 2025-05-15 |
| 2024-12-31 | -$76.03M 10-K · filed 2026-03-30 |
| 2024-09-30 | -$70.15M 10-Q · filed 2024-11-07 |
| 2024-06-30 | -$65.64M 10-Q · filed 2024-08-08 |
| 2024-03-31 | -$60.69M 10-Q · filed 2024-05-09 |
| 2023-12-31 | -$55.24M 10-K · filed 2025-03-27 |
| 2023-09-30 | -$51.06M 10-Q · filed 2023-11-08 |
| 2023-06-30 | -$47.90M 10-Q · filed 2023-08-09 |
| 2023-03-31 | -$43.15M 10-Q · filed 2023-05-09 |
| 2022-12-31 | -$39.28M 10-K · filed 2024-03-18 |
| 2022-09-30 | -$35.90M 10-Q · filed 2022-11-07 |
| 2022-06-30 | -$33.64M 10-Q · filed 2022-08-08 |
| 2022-03-31 | -$29.14M 10-Q · filed 2022-05-03 |
| 2021-12-31 | -$25.02M 10-K · filed 2023-03-20 |
| 2021-09-30 | -$21.48M 10-Q · filed 2021-11-01 |
| 2021-06-30 | -$17.43M 10-Q · filed 2021-07-29 |
| 2021-03-31 | -$15.11M 10-Q · filed 2021-05-03 |
| 2020-12-31 | -$12.66M 10-K · filed 2022-03-10 |
| 2020-09-30 | -$9.76M 10-Q · filed 2020-10-29 |
| 2020-06-30 | -$8.06M 10-Q · filed 2020-07-30 |
| 2019-12-31 | -$6.75M 10-K · filed 2021-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |